Table 2.
Continuous glucose monitoring parameters.
| HYPO n = 18 |
NO-HYPO n = 10 | p Value HYPO vs. NO-HYPO | |
|---|---|---|---|
| Mean IG (mg/dL) | 90 ± 8 | 104 ± 14 | 0.009 * |
| Mean IG peak (mg/dL) | 195 ± 41 | 203 ± 58 | 0.832 * |
| Mean IG nadir (mg/dL) | 43 ± 4 | 53 ± 9 | 0.001 * |
| CV (%) | 26 ± 7 | 20 ± 6 | 0.031 |
| SD (mg/dL) | 24.0 ± 6.9 | 21.9 ± 9.5 | 0.506 |
| MAGE (mg/dL) | 69.8 ± 29.7 | 54.2 ± 15.4 | 0.155 |
| % time spent at IG < 54 mg/dL | 3.5 ± 3.3 | 0.15 ± 0.17 | <0.001 |
| % time spent at IG 54–70 mg/dL | 16.0 ± 10.1 | 3.2 ± 3.5 | <0.001 |
| % time spent at IG 71–130 mg/dL | 73.5 ± 13.9 | 85.9 ± 13.0 | 0.035 |
| % time spent at IG 131–190 mg/dl | 6.4 ± 5.0 | 9.4 ± 10.6 | 0.524 * |
| % time spent at IG > 190 mg/dL | 0.5 ± 0.6 | 1.3 ± 3.3 | 0.689 * |
IG: interstitial glucose; CV: coefficient of variation; SD: standard deviation of blood glucose; MAGE: mean amplitude of glucose excursions. * Mann−Whitney U-test was used for non-normally distributed variables.